Papanicolaou smear sensitivity for the of adenocarcinoma of the cervix

Cancer

Volumn 93, Issue 1, 2001, Pages 8-15

  Krane, J F ^a   Granter, S R ^b   Trask, C E ^b   Hogan, C L ^b   Lee, K R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Adenocarcinoma; Adenocarcinoma in situ; Cervicovaginal smear tests; Cervix; Cytology; Papanicolaou smear test; Uterus

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; METAPLASIA; PAPANICOLAOU TEST; PRIORITY JOURNAL; SAMPLING; SCREENING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 0035945968     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010225)93:1<8::aid-cncr9001>3.0.co;2-k     Document Type: Article

References (33)

1. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas
2. Increase of cervical adenocarcinoma: A report of 520 cases of cervical carcinoma including 112 tumors with glandular elements
3. Increased incidence of adenocarcinoma of uterine cervix
4. Recent trends in cervix uteri cancer
5. Expanded cytologic criteria for the diagnosis of adenocarcinoma in sim of the cervix and related lesions
6. Exfoliative cytology of in situ and microinvasive adenocarcinoma of the uterine cervix
7. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri
8. Morphology of adenocarcinoma in situ and microinvasive adenocarcinoma of the uterine cervix. A cytologic and ultrastructural study
9. Adenocarcinoma in situ in cervical smears with a small cell (endometrioid) pattern: Distinction from cells directly sampled from the upper endocervical canal or lower segment of the endometrium
10. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix
11. Endocervical glandular atypia and adenocarcinoma: A correlation of cytology and histology
12. Early endocervical glandular neoplasia. I. Histomorphology and cytomorphology
13. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. I. Adenocarcinoma in situ
14. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: No strong evidence of benefit
15. Results of prior cytologic screening in patients with a diagnosis of stage I carcinoma of the cervix
16. Adenocarcinoma of the uterine cervix: Cytological evidence of a long preclinical evolution
17. Efficacy of screening for cervical squamous and adenocarcinoma. The Dutch experience
18. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings
19. Adenocarcinoma of the cervix: Histopathologic and clinical features
20. The role of cytology in the diagnosis and follow-up of patients with cervical adenocarcinoma
21. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases
22. The effects of endocervical canal topography, tubal metaplasia, and high canal sampling on the cytologic presentation of nonneoplastic endocervical cells
23. Endometrial cells of the "lower uterine segment" (LUS) in cervical smears obtained by endocervical brushings: A source of potential diagnostic pitfall
24. Glandular cells derived from direct sampling of the lower uterine segment in patients status post-cervical cone biopsy. A diagnostic dilemma
25. Adenocarcinoma in situ with a small cell (endometrioid) pattern in cervical smears: A test of the distinction from benign mimics using specific criteria
26. The cytological features of invasive adenocarcinoma of the cervix uteri
27. The cytological features and DNA content of cervical adenocarcinoma
28. Cytologic findings in minimal deviation adenocarcinoma (adenoma malignum) of the cervix. A report of seven cases
29. Adenoma malignum of the cervix. Cytologic findings
30. Cytologic features of well-differentiated villoglandular adenocarcinoma of the cervix
31. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening
32. Risk factors for rapid-onset cervical cancer